Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
D.F. Hayes.
Do we need prognostic factors in nodal-negative breast cancer? Arbiter.
Eur J Cancer, 36 (2000), pp. 202-306
[2.]
C. López Otin, E.P. Diamandis.
Breast and prostate cancer: an analysis of common epidemiological, genetic, and biochemical features.
Endocr Rev, 19 (1998), pp. 365-396
[3.]
A. Volpi, F. De Paola, O. Nanni, A.M. Granato, P. Bajorko, A. Becciolini, et al.
Prognostic significance of biologic markers in node negative breast cancer patients: a prospective study.
Breast Cancer Res Treat, 63 (2000), pp. 181-192
[4.]
R. Heimann, F. Lan, R. McBride, S. Hellman.
Separating favorable from unfavorable prognostic markers in breast cancer: the role of Ecaderin.
Cancer Res, 60 (2000), pp. 298-304
[5.]
M. Morini, M. Mottolese, N. Ferrari, F. Ghiorzo, S. Buglioni, R. Mortarin, et al.
The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP9) activity.
Int J Cancer, 87 (2000), pp. 336-342
[6.]
N.S. Fedarko, B. Fohr, P.G. Robey, M.F. Young, L.W. Fisher.
Factor H binding to bone sialoprotein and osteopontin enables tumor evasion of complement-mediated attack.
J Biol Chem, 275 (2000), pp. 16666-166672
[8.]
W.F. Anderson, K.C. Chu, N. Chatterjee, O. Brawkey, L.A. Brinton.
Tumor variants by hormone receptor expression in white patients with node negative breast cancer from the surveillance, epidemiology and end results database.
J Clin Oncol, 19 (2001), pp. 18-27
[9.]
J. Schneider, M. Pollan, A. Ruibal, E. Jiménez, A.R. Lucas, M.I. Núñez, et al.
Histologic grade and CD44 are independent predictors of axillary lymph node invasion in early (T1) breast cancer.
Tumor Biol, 20 (1999), pp. 319-330
[10.]
R. Seshadri, D.J. Horsfall, K. McCaul, A.S. Leong.
A simple index to predict prognosis independent of axillary node information in breast cancer.
Aust NZJ Surg, 67 (1997), pp. 765-770
Copyright © 2001. Asociación Española de Cirujanos
